• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Airway abundance of predicts response to azithromycin in adults with persistent uncontrolled asthma.

作者信息

Taylor Steven L, Ivey Kerry L, Gibson Peter G, Simpson Jodie L, Rogers Geraint B

机构信息

SAHMRI Microbiome Research Laboratory, Flinders University College of Medicine and Public Health, Adelaide, Australia

Microbiome and Host Health, South Australia Health and Medical Research Institute, Adelaide, Australia.

出版信息

Eur Respir J. 2020 Oct 1;56(4). doi: 10.1183/13993003.00194-2020. Print 2020 Oct.

DOI:10.1183/13993003.00194-2020
PMID:32366495
Abstract
摘要

相似文献

1
Airway abundance of predicts response to azithromycin in adults with persistent uncontrolled asthma.气道中 的丰度可预测持续性未控制哮喘成人患者对阿奇霉素的反应。 （你提供的原文“Airway abundance of ”这里似乎有缺失内容）
Eur Respir J. 2020 Oct 1;56(4). doi: 10.1183/13993003.00194-2020. Print 2020 Oct.
2
Dynamics of clarithromycin and azithromycin efficacies against experimental Haemophilus influenzae pulmonary infection.克拉霉素和阿奇霉素对实验性流感嗜血杆菌肺部感染疗效的动态变化
Antimicrob Agents Chemother. 1998 Sep;42(9):2385-90. doi: 10.1128/AAC.42.9.2385.
3
Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.阿奇霉素、克拉霉素和β-内酰胺类药物对小鼠实验性流感嗜血杆菌所致支气管肺炎的疗效。
J Antimicrob Chemother. 2001 Sep;48(3):425-30. doi: 10.1093/jac/48.3.425.
4
Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media.中耳炎患者临床分离株中耐抗生素肺炎链球菌和β-内酰胺酶阳性流感嗜血杆菌的发生率。
Pediatr Infect Dis J. 1996 Sep;15(9 Suppl):S3-9. doi: 10.1097/00006454-199609009-00001.
5
Azithromycin Pharmacodynamics against Persistent Haemophilus influenzae in Chronic Obstructive Pulmonary Disease.阿奇霉素对慢性阻塞性肺疾病中持续性流感嗜血杆菌的药效动力学
Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.01995-17. Print 2018 Feb.
6
Emergence and molecular characterization of Haemophilus influenzae harbouring mef(A).携带mef(A)的流感嗜血杆菌的出现及分子特征分析
J Antimicrob Chemother. 2017 Mar 1;72(3):948-949. doi: 10.1093/jac/dkw501.
7
Are the antimicrobial properties of macrolides required for their therapeutic efficacy in chronic neutrophilic airway diseases?大环内酯类药物在慢性嗜中性气道疾病中的治疗效果是否需要其抗菌特性？
Thorax. 2015 May;70(5):401-3. doi: 10.1136/thoraxjnl-2015-207080.
8
In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae.泰利霉素（HMR3647）对肺炎链球菌和流感嗜血杆菌的体内疗效。
Antimicrob Agents Chemother. 2001 Nov;45(11):3250-2. doi: 10.1128/AAC.45.11.3250-3252.2001.
9
In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin.180株流感嗜血杆菌临床分离株对氨苄西林、阿莫西林/克拉维酸、头孢克洛、头孢呋辛、头孢噻肟、克拉霉素和阿奇霉素的体外敏感性。
Acta Clin Belg. 1996;51(4):237-43. doi: 10.1080/22953337.1996.11718516.
10
Influence of variations in test methods on susceptibility of Haemophilus influenzae to ampicillin, azithromycin, clarithromycin, and telithromycin.检测方法的差异对流感嗜血杆菌对氨苄西林、阿奇霉素、克拉霉素和泰利霉素敏感性的影响。
J Clin Microbiol. 2001 Jan;39(1):43-6. doi: 10.1128/JCM.39.1.43-46.2001.

引用本文的文献

1
in bronchiectasis.在支气管扩张症中。
Eur Respir Rev. 2025 Aug 6;34(177). doi: 10.1183/16000617.0007-2025. Print 2025 Jun.
2
Sputum quality affects assessment of airway microbiology in childhood asthma.痰液质量影响儿童哮喘气道微生物学评估。
Respir Res. 2025 Jun 4;26(1):209. doi: 10.1186/s12931-025-03266-x.
3
Choosing the Right Biologic for the Right Patient With Severe Asthma.为重度哮喘患者选择合适的生物制剂
Chest. 2025 Feb;167(2):330-342. doi: 10.1016/j.chest.2024.08.045. Epub 2024 Sep 6.
4
Species-level, metagenomic and proteomic analysis of microbe-immune interactions in severe asthma.严重哮喘中微生物-免疫相互作用的种属水平、宏基因组学和蛋白质组学分析。
Allergy. 2024 Nov;79(11):2966-2980. doi: 10.1111/all.16269. Epub 2024 Aug 11.
5
Characterization of bacterial and viral pathogens in the respiratory tract of children with HIV-associated chronic lung disease: a case-control study.儿童人类免疫缺陷病毒相关慢性肺部疾病患者呼吸道中细菌和病毒病原体的特征：病例对照研究。
BMC Infect Dis. 2024 Jun 26;24(1):637. doi: 10.1186/s12879-024-09540-5.
6
Application of Microbiome-Based Therapies in Chronic Respiratory Diseases.基于微生物组的疗法在慢性呼吸系统疾病中的应用。
J Microbiol. 2024 Mar;62(3):201-216. doi: 10.1007/s12275-024-00124-1. Epub 2024 Apr 18.
7
Phenotyping the Responses to Systemic Corticosteroids in the Management of Asthma Attacks (PRISMA): protocol for an observational and translational pilot study.表型分析全身性皮质类固醇治疗哮喘发作的反应（PRISMA）：一项观察性和转化性先导研究方案。
BMJ Open Respir Res. 2023 Nov;10(1). doi: 10.1136/bmjresp-2023-001932.
8
Severe Asthma and Biological Therapies: Now and the Future.重度哮喘与生物疗法：现状与未来
J Clin Med. 2023 Sep 8;12(18):5846. doi: 10.3390/jcm12185846.
9
A clinicians' review of the respiratory microbiome.临床医生对呼吸道微生物群的综述。
Breathe (Sheff). 2022 Mar;18(1):210161. doi: 10.1183/20734735.0161-2021. Epub 2022 Apr 5.
10
Non-typeable airways infection: the next treatable trait in asthma?非典型气道感染：哮喘的下一个可治疗特征？
Eur Respir Rev. 2022 Sep 20;31(165). doi: 10.1183/16000617.0008-2022. Print 2022 Sep 30.